Atopic Dermatitis News and Research

RSS
Atopic dermatitis is a long-term skin disease. "Atopic" refers to a tendency to develop allergy conditions. "Dermatitis" means swelling of the skin. Atopic dermatitis is most common in babies and children. But it can happen to anyone. People who live in cities and dry climates may be more likely to get this disease. When children with atopic dermatitis grow older, this problem can improve or go away. But the skin may stay dry and easy to irritate. At other times, atopic dermatitis is a problem in adulthood. You can't "catch" the disease or give it to other people.
Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

Eczema can increase patients' risk of developing several other health conditions

Eczema can increase patients' risk of developing several other health conditions

Study finds link between eczema and S. aureus bacteria

Study finds link between eczema and S. aureus bacteria

Early-life peanut consumption feasible and nutritionally safe for children, study finds

Early-life peanut consumption feasible and nutritionally safe for children, study finds

Subcutaneous treatment with cord blood stem cells improves eczema symptoms

Subcutaneous treatment with cord blood stem cells improves eczema symptoms

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Domestic water hardness linked to eczema risk in children

Domestic water hardness linked to eczema risk in children

Study shows canine AD shares significant features of human version

Study shows canine AD shares significant features of human version

Researchers observe worrisome increase in anaphylaxis rate

Researchers observe worrisome increase in anaphylaxis rate

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Asthma in childhood may increase risk of shingles

Asthma in childhood may increase risk of shingles

New Northwestern Medicine project aims to understand effects of asthma, eczema on children

New Northwestern Medicine project aims to understand effects of asthma, eczema on children

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

First comprehensive genomic and biologic study of top skin disease-causing microbes

First comprehensive genomic and biologic study of top skin disease-causing microbes

Researchers identify seven genetic risk loci involved in atopic march

Researchers identify seven genetic risk loci involved in atopic march

Immune submits Bertilimumab IND application to FDA for treatment of Bullous Pemphigoid

Immune submits Bertilimumab IND application to FDA for treatment of Bullous Pemphigoid

OSU researchers develop new approach to treat eczema

OSU researchers develop new approach to treat eczema

Immune Pharmaceuticals’ CEO establishes stock trading plan

Immune Pharmaceuticals’ CEO establishes stock trading plan

Experts explain how nutrition can influence inflammatory processes and help lower chronic diseases risk

Experts explain how nutrition can influence inflammatory processes and help lower chronic diseases risk